Recent News for SVRA - Savara, Inc.

Date Title
Apr 9 7 Penny Stocks With Interesting Catalysts
Apr 5 48 Biggest Movers From Thursday
Apr 1 Savara on the rise as prominent hedge funds reveals 6% stake
Mar 31 CLF, CHWY, OCGN and LCTX among premarket gainers
Mar 30 2 “Strong Buy” Penny Stocks That Could Go Boom
Mar 23 Sizing Up Savara
Mar 21 Independent Director David Ramsay Just Bought 565% More Shares In Savara Inc. (NASDAQ:SVRA)
Mar 18 Do Options Traders Know Something About Savara (SVRA) Stock We Don't?
Mar 17 25 Stocks Moving in Wednesday's Pre-Market Session
Mar 16 Mid-Afternoon Market Update: Crude Oil Down 1%; SunLink Health Systems Shares Spike Higher
Mar 16 Thinking About Buying Stock In AstraZeneca, Apple, McDonald's, Savara Or Jabil?
Mar 16 Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2021
Mar 16 Biogen expected to receive FDA nod for Alzheimer’s therapy and Solid Bioscience upgraded in today’s analyst action
Mar 15 Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2021
Mar 15 Savara Announces Closing of $130 Million Public Offering Following Full Exercise of Underwriters’ Option
Mar 15 Savara on the rise after Oppenheimer touted its experimental lung therapy
Mar 15 Lilly’s Alzheimer's data fail to impress Wall Street; Savara climbs on Oppenheimer initiation in pre-market analyst action
Mar 11 Savara prices $113M public offering
Mar 11 Savara Announces Pricing of Public Offering of Common Stock
Mar 11 Savara drops 19% on launch of stock offering
Mar 10 Savara updates on the trial for rare lung disease
Mar 10 Savara Announces Proposed Public Offering of Common Stock
Feb 5 Is the Options Market Predicting a Spike in Savara (SVRA) Stock?
Jan 21 Is Savara (NASDAQ:SVRA) Using Too Much Debt?
Dec 10 Is SVRA A Good Stock To Buy Now?
Back to the Main SVRA Page...